Pembrolizumab with chemoradiotherapy as treatment for muscle invasive bladder cancer: Analysis of safety and efficacy of the PCR-MIB phase II clinical trial (ANZUP 1502)

AJ Weickhardt, F Foroudi, J Xie, K Kanojia, M Sidhom, A Pal, P Grimison, A Zhang, S Ng, C Tang, E Hovey, C Chen, G Hruby, A Guminski, M Mcjannett, CJ Conduit, N Lawrentschuk, B Tran, ID Davis, D Hayne